Biopharmas raising money in public or private financings, including: 4D, 9 Meters, Arvinas, Atsena, Aytu, Bioatla, Biocardia, Bone Therapeutics, Cellectis, Enveda, Exo, Forma, Junshi, Nanobiotix, Neurogene, Neuron23, Ocular Therapeutix, Phathom, Protagonist, Qualigen, Revitope, Scopus, Soligenix, Vivace.

New hires and promotions in the biopharma industry, including: AB2, Aquestive, Atai, Cardurion, Enara, Leo, Lidds, Kymera, Recro, Rockwell, SAB, Sage, Xbrane, Xwpharma.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, Anitoa, Binx Health, Ellume, Exero Medical, Genetesis, Horiba, Roche, Seaspine, Switch Health.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acist Medical Systems, Ambu, Baylis Medical, Bw-Tec, Corindus Vascular Robotics, Corvent Medical, Ekpac Healthcare, Genscript Biotech, Glytec, Innobation, Johnson & Johnson, Mauna Kea Technologies, Machine Solutions, Medis Medical Imaging, Oxford Nanopore Technologies, Sensorion, Sensyne Health, Siemens Healthineers, Sonova Holding, Sourcebio International, Takeda Pharmaceutical, Telix Pharmaceuticals, Thinkgenetic, Veracyte.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biodesix, Medtronic, Numares.

Med-tech firms raising money in public or private financings, including: Brain Scientific, Nference, Ocular Therapeutix, Singlera Genomics, Viewpoint Molecular Targeting.

New hires and promotions in the med-tech industry, including: Irhythm Technologies, Neurocytonix, Pelvital, Tissium.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Antengene, Astrazeneca, Beigene, Biogen, Biontech, Chugai, Codagenix, Cyxone, Daiichi Sankyo, Eisai, Gannex, Henlius, Ix, Open Orphan, Pfizer, Sinovac, Sorrento, Swedish Orphan Biovitrum, Takeda.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Abivax, Advaccine, Amarin, Astrazeneca, Biontech, Curevac, Daiichi Sankyo, Eli Lilly, EOC, Immutep, Incyte, Innovent, Inovio, Junshi, Kazia, Kintor, Mitsubishi Tanabe, Moderna, Novartis, Pfizer, Pharming, Tychan, Vicore.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: 3Sbio, Allarity, Anixa, Antengene, Applied Biomath, Arcus, Ascentage, Astrazeneca, Axcelead Drug Discovery, Biocytogen Boston, Bristol Myers Squibb, Cipla, Citius, Crescendo Biologics, Cure, Eisai, Eureka, Evommune, Fera, Fusion Antibodies, Halix, Hemoshear, Hummingbird, Hyundai, Immunitybio, Immunoprecise Antibodies, Inveniai, Kazia, Kyowa Kirin, Litevax, Moderna, Monopar, Nicox, Oncoceutics, Ontochem, Orgenesis, Overland, Pharmablock Sciences, Recce, Roche, Securabio, Sunshine, Synedgen, Taiho, Takeda, Vaccibody, Verseau, Virpax, Wuxi Biologics, Xencor.